1. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial. Issue 15 (9th October 2018) Authors: Haynes, Richard; Judge, Parminder K.; Staplin, Natalie; Herrington, William G.; Storey, Benjamin C.; Bethel, Angelyn; Bowman, Louise; Brunskill, Nigel; Cockwell, Paul; Hill, Michael; Kalra, Philip A.; McMurray, John J.V.; Taal, Maarten; Wheeler, David C.; Landray, Martin J.; Baigent, Colin; Hayne... Journal: Circulation Issue: Volume 138:Issue 15(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Developing a patient and public involvement intervention to enhance recruitment and retention in UK surgical trials (PIRRIST). (December 2016) Authors: Crocker, J.C.; Rees, S.; Locock, L.; Petit-Zeman, S.; Chant, A.; Treweek, S.; Cook, J.A.; Farrar, N.; Woolfall, K.; Bostock, J.; Bowman, L.; Bulbulia, R. Journal: International journal of surgery Issue: Volume 36(2016)Supplement 2 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A CASE-CONTROL ANALYSIS OF UTILIZATION OF HEALTHCARE SERVICES AND COSTS BY WOMEN WITH AND WITHOUT OVARIAN CANCER. Issue 1 (1st March 2003) Authors: Kutikova, L.; Bowman, L.; Chang, S.; Long, S. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P639: OUTCOMES FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA PREVIOUSLY TREATED WITH A COVALENT BTK AND BCL2 INHIBITOR IN THE UNITED STATES: A REAL-WORLD DATABASE STUDY. (23rd June 2022) Authors: Mato, A. R.; Chen, Y.; Girvan, A. C.; Hess, L. M.; Bowman, L.; Abada, P.; Konig, H.; Walgren, R. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IDF21-0188 Impact of adverse events on hospital costs and health-related quality of life in people with diabetes. (April 2022) Authors: Keng, M.J.; Armitage, J.; Bowman, L.; Leal, J.; Mihaylova, B. Journal: Diabetes research and clinical practice Issue: Volume 186:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17–25]. (September 2018) Authors: Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D.; Okusaka, Takuji; Bowman, L.; Cui, Zhanglin... Journal: European journal of cancer Issue: Volume 100(2018) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study. (August 2017) Authors: Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D.; Okusaka, Takuji; Bowman, L.; Cui, Zhanglin... Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗